Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-11

Clinical Trial Update: Safety and Tolerability of Single and Multiple Doses of Neumifil [Phase 1]

View source ↗

Summary

Phase 1 trial update on Neumifil assessing safety and tolerability after single and multiple doses; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neumifil (neumifil)

Snippet

Sponsor: Pneumagen Ltd. | Conditions: Viral Respiratory Tract Infection | Phase 1 | Status: COMPLETED | Results posted: 2024-01-11